We sought to further study the relationship between aneurysm location and maximum SAH burden in patients enrolled in a prospective randomized controlled trial. In addition to assessing differences in bleed thickness with different aneurysm types, we also investigated whether differences in the location of ruptured aneurysms can further influence the risk for developing symptomatic or radiographic vasospasm.
Methods

Study Criteria and Data Acquisition
We analyzed 250 patients with SAH who had been enrolled in a prospective randomized controlled trial and reviewed their hospital charts retrospectively for vasospasm occurrence (whether radiographic or clinical) and clot thickness; these variables had not been collected in the prospective study. The methods for determination of these variables have been published previously. 9 All other data points, including demographics, aneurysm characteristics, aneurysm location, aneurysm size, presenting clinical neurological status, neurological outcomes (modified Rankin Scale [mRS] and Glasgow Outcome Scale scores), and treatment modality, as well as other data were collected in a prospective and blinded fashion in the Barrow Ruptured Aneurysm Trial (BRAT). 6, 8 This study was approved by the St. Joseph's Hospital Institutional Review Board.
We excluded 29 patients with nonaneurysmal SAH. In the initial report, 9 we excluded 2 patients who did not have admission CT scans available for review and 1 patient who died before treatment; these patients were also excluded for this report. In addition, for this report, we also excluded 2 patients with cavernous internal carotid artery (ICA) aneurysms because of their extradural location. Aneurysm treatment included coil embolization or microsurgical clip placement.
Clinical Course
Patients underwent routine and standardized SAH treatment in an intensive care unit as previously described, 8, 9 including ventricular drainage when necessary, nimodipine use in all patients, and routine transcranial Doppler monitoring 3 times weekly. Hypertensive therapy was instituted as required by symptomatic or radiographic vasospasm. Most patients received routine surveillance conventional angiography approximately 7 days after ictus, even in the absence of vasospasm. A minority of patients who were asymptomatic with a good clinical examination and assumed low risk for vasospasm did not undergo conventional angiography. Computed tomography angiography was obtained for neurological status alteration (often in the setting of increased transcranial Doppler velocities), followed by hypertensive therapy and then conventional angiography, if warranted by the CT angiography findings. Endovascular intervention, including balloon angioplasty or calcium channel blocker infusion, was performed based on angiographic findings in patients with symptomatic vasospasm (clinical deterioration from delayed cerebral ischemia).
Vasospasm Determination
The methods for determination of vasospasm used in this study have been published previously. 9 The presence of radiographic vasospasm and degree of vasospasm were determined by an independent neuroradiologist. Conventional angiography was obtained in all but 3 patients; 1 patient each underwent CT angiography, MR angiography, or CT perfusion as confirmatory tests for vasospasm in the absence of angiography. Symptomatic vasospasm, also referred to as clinical deterioration attributable to delayed cerebral ischemia, was recorded for patients with neurological findings concurrent to radiographic vasospasm occurring in the affected vascular territory, or in patients with radiographic vasospasm who responded to hypertensive therapy with resolution of their symptoms. Patients with symptomatic or radiographic vasospasm with clear evidence of infarction on either CT or MRI (for all confirmed cases except 1 case) were tabulated as having stroke (cerebral infarction) attributable to vasospasm.
Barrow Neurological Institute Scale
The Barrow Neurological Institute (BNI) Scale 9 determines the risk for vasospasm based on SAH thickness. This scale documents the maximum clot thickness on 32-slice, axial, noncontrast head CT scans in any subarachnoid space with the thickness measured perpendicular to the direction of the long axis of the cistern or fissure in which it is measured. Measurements were made based on the patients' CT scans within the first 3 hours of admission by 1 neurosurgeon (D.A.W.) who was blinded to the clinical course and vasospasm incidence in all patients. The reliability of the scale was confirmed by 2 additional neurosurgeons in a blinded fashion; when comparing the interobserver variability of the Fisher scale to the BNI scale, there was a mean k coefficient of 0.65 for the BNI scale, which was better than the k coefficient (0.51) for the Fisher scale. The intraobserver variability was also superior for the BNI scale (mean 0.81) compared with the Fisher scale (mean 0.35). The scale consists of 5 grades: no blood on CT (Grade 1), clot thickness less than 5 mm (Grade 2), clot thickness 5-10 mm (Grade 3), clot thickness 10-15 mm (Grade 4), and clot thickness greater than 15 mm (Grade 5).
Grouping of Aneurysms by Location
The aneurysms in the patients were grouped into 1 of 6 locations based on cistern or fissure proximity ( Table 1 , Fig. 1 ). Intradural ICA aneurysms were placed into a single location group. Another group was designated as the vertebral artery (VA) location. This group included patients with aneurysms of the intradural VA, the posterior inferior cerebellar artery (PICA), and those at or proximal to the vertebrobasilar junction. The third group included basilar artery (BA) aneurysms, including aneurysms of the anterior inferior cerebellar artery origin, superior cerebellar artery origin, basilar trunk, basilar apex, and P 1 / P 2 segment of the posterior cerebral artery. The fourth group included aneurysms of the middle cerebral artery (MCA), almost exclusively located at the MCA bifurcation. The fifth group included aneurysms involving the pericallosal arteries (A 2 /A 3 or A 3 /A 4 ), and the final group was designated as anterior communicating artery (ACoA) aneurysms, which also included aneurysms classified as at the A 1 /A 2 junction. In this fashion, we were able to account for all aneurysms that were eligible for inclusion with the exception of 2 cavernous ICA aneurysms; these were excluded due to their extradural location.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism Software (GraphPad Inc.). For categorical variables, the Fisher exact test was used when comparing 2 groups with 2 outcome categories. The chi-square test for independence was used when analyzing contingency data for more than 2 groups; in cases of small sample sizes in certain contingency groups, 2 groups were combined into a single group, because the chi-square test for independence is not valid when groups contain zero patients. In 1 instance, the Fisher exact test was used rather than the chi-square test to obtain statistical significance for a 2 × 6 matrix with sparsely populated cells (Table 2) ; the analysis was performed using an exact analysis (http://www. physics.csbsju.edu/stats/exact_NROW_NCOLUMN_ form.html). For continuous variables, the Mann-Whit ney (nonparametric) test was used for comparing 2 populations with continuous data, while the Kruskal-Wallis (non para metric) test was used for comparing more than 2 groups with continuous data. Univariate linear regression analysis was used to compare the relationship between clot thickness and aneurysm size using the Pearson correlation coefficient; p values < 0.05 were considered significant. Continuous values were reported as means ± SD; figures depicting means are shown with error bars depicting the standard error of the mean.
Results
Two hundred sixteen patients were included in this study (57 males and 159 females, mean age 53.7 ± 11.9 years). Seventy patients had aneurysms located in the intradural ICA, 16 had aneurysms in the VA location, 18 in the BA segment, 36 had MCA aneurysms, 9 had pericallosal aneurysms, and 67 patients had ACoA aneurysms (Table 1) .
Demographic Data
Overall, no significant difference was found on presentation between age and aneurysm location or between Hunt & Hess grade and aneurysm location ( Table 2) . Differences in sex distribution across the 6 groups of aneurysms were significant; all aneurysm locations except the VA location group had a significantly higher proportion of female patients than male patients (Table 2) .
Aneurysm Characteristics
No significant difference in aneurysm size existed between groups ( Table 2 ). The mean aneurysm size for the entire group of 216 patients was 6.6 ± 3.3 mm. When analyzing aneurysm size as a function of the BNI scale, no statistically significant difference in the mean aneurysm size was found between any of the 5 BNI scale grades (p = 0.92; Fig. 2A ). Using linear regression to compare the relationship of aneurysm size to SAH clot thickness in a fissure or cistern revealed a positive correlation, but this 
Distribution Between Patients Receiving Clip Placement or Coil Embolization
There was no statistical difference in the mean aneurysm size between the coil embolization and clip placement groups in the groups studied here (p = 0.460, Table  3 ). There was also no statistical difference in the overall distribution of aneurysm locations in the coiled and clipped groups (p = 0.493, chi-square test).
Subarachnoid Hemorrhage Clot Burden on Presentation
The mean clot thickness measured on presentation CT was 6.4 ± 4.6 mm. Comparing the 6 aneurysm location groups overall revealed no statistically significant difference in clot thickness (p = 0.898; Table 2 ). The overall average BNI scale grade was 2.8 ± 0.9; no significant difference in BNI scale grade was found between aneurysm locations (p = 0.778; Table 2 ). The largest mean clot thickness (7.1 mm) and highest BNI scale grade (3.1 on average) occurred in MCA aneurysms. The smallest mean clot thickness (5.3 mm) and lowest BNI scale grade (2.7 on average) occurred in pericallosal aneurysms.
Vasospasm Incidence
Vasospasm, either radiographic or clinical, occurred in 107 (50.7%) of 211 patients with recorded data. There was a much higher incidence of any vasospasm (77.7%) at the pericallosal location despite the lowest mean clot thickness at this location (Fig. 2C) . Radiographic vasospasm occurred in 106 (50.2%) of 211 patients. No significant difference in the incidence of radiograph vasospasm was found between aneurysm groups (p = 0.66; Table 2 ).
Symptomatic vasospasm (clinical deterioration from delayed cerebral ischemia) occurred in 47 patients (22%; Table 2 ). The pericallosal aneurysm location had a 56% incidence of symptomatic vasospasm. Comparing the incidence in this aneurysm location to symptomatic vasospasm at all other locations (55% vs 22%), the increased risk for pericallosal artery aneurysms was significant (p = 0.0261, Fisher exact test; OR 4.85, RR 2.71; Table 4 ). In patients with symptomatic (clinical) vasospasm, 71.7% had intraventricular hemorrhage compared with 55.4% of patients who did not exhibit symptomatic vasospasm, but the difference was not statistically significant (p = 0.0622).
There was also no significant difference in the incidence of infarcts attributed to vasospasm between groups (p = 0.25; Table 2 ). However, when comparing the mean clot thickness in 14 patients who had a stroke (cerebral infarction) attributed to vasospasm versus the mean clot thickness in the 202 patients who did not, the difference was significant (9.71 vs 6.15 mm, respectively; p = 0.004).
Outcomes
The mean mRS score in 190 patients at the 1-year follow-up was 1.9 ± 1.9. There was no significant difference in 1-year mRS score overall (p = 0.175; Table 2 ). The VA aneurysm group had a worse mean mRS score at 1 year (3.0 ± 2.2) compared with all other aneurysms (mean = 1.8 ± 1.8); this difference was significant (p = 0.0249; Fig. 2D ).
Outcomes were also dichotomized into 2 groups: good outcome (mRS score 0-2) and poor outcome (mRS score 3-6). There were good outcomes in 137 (72%) of 190 patients. The difference in good outcome occurrence between the 6 locations was not significant (p = 0.098; Table 2 , Fig. 2E ). All mRS outcomes at the 1-year followup are listed in Table 5 . When posterior circulation and pericallosal aneurysms were analyzed together, only 20 (53%) of 38 patients had 1-year mRS scores of 0-2. The likelihood of a good outcome at 1 year was 1.5 (RR) or 3.0 (OR) times higher for an aneurysm at all other locations compared with the posterior circulation and pericallosal artery aneurysms (77% vs 53%, p = 0.0044; Fig. 2F ).
Discussion
Delayed ischemia from cerebral vasospasm is the greatest cause of morbidity in patients with SAH. 3, 5, 10 Identifying patients at the greatest risk for cerebral vasospasm is an important prognosticator in the setting of SAH and may identify patients who will likely need hypertensive therapy, or potential endovascular treatment of vasospasm, or both. A comprehensive review of the literature by Harrod et al. from 1996 Harrod et al. from to 2005 showed that the only factor that has shown to be predictive of cerebral vasospasm is the burden of blood at the time of SAH. 3 A previous study from our center corroborates this finding and stratifies the maximum clot burden into 5 categories.
9
In a study of 41 patients, the same group responsible for the Fisher scale 2 investigated the relation of cerebral vasospasm to the extent and location of blood. 5 Their findings indicated that the location of blood is well correlated with the arterial territory that later develops severe vasospasm, 5 as previous authors have re-demonstrated when correlating the territory of cerebral infarction with aneurysm location. 7 However, the study was limited to 41 patients, of whom even fewer actually experienced vasospasm. 5 In a retrospective study of 211 patients, another group examined predictors of vasospasm and found that only age and modified Fisher grade were predictive of vasospasm. 10 Aneurysm location in their study was stratified into 4 groups: no aneurysm, anterior circulation, posterior circulation, or unclear. 10 A retrospective review of 178 patients investigated factors related to symptomatic cerebral vasospasm, but while aneurysm location was described, it was not mentioned in the analysis of predictors of vasospasm, perhaps due to a large number of aneurysm locations (n = 12).
In our series of 216 patients in a randomized controlled trial with treated ruptured aneurysms, we investigated the relationship between ruptured aneurysm location (when stratified into 6 groups) and vasospasm. Concurrently, we sought to address the influence of the ruptured aneurysm type on maximum clot burden, the most influential of all predictors of cerebral vasospasm in SAH. Our findings demonstrated that when stratified into 6 different aneurysm locations, maximum SAH clot thickness or burden did not differ between ruptured aneurysm groups. Although the ruptured aneurysm location groups had similar overall clot burden, the effect of this similar clot burden on cerebral vasospasm also did not vary by location; that is, most groups had similar (nonstatistically different) rates of vasospasm, radiographic or symptomatic in the setting of nonstatistically different clot burden. The exception was the pericallosal artery aneurysm group; these aneurysms had the lowest overall clot burden. They also had the highest risk of symptomatic vasospasm or clinical deterioration from delayed cerebral ischemia (p = 0.026).
Several notable findings included the highest average maximum clot thickness at the MCA location, despite a lower than average overall vasospasm risk. The opposite was true for pericallosal aneurysms. Pericallosal aneurysms rupture into the confines of the interhemispheric fissure, where it is possible for subarachnoid blood to cause irritation of fairly small caliber vessels (the distal anterior cerebral arteries) from both hemispheres. This symptomatic vasospasm may be related to the smaller diameter of the pericallosal arteries at baseline, which may make them more prone to the deleterious effects of further narrowing; this possibility requires further investigation. The pericallosal group consisted of a small sample size of just 9 patients; although the result was statistically significant, it remains a small sample of patients. Aneurysms of the MCA rupture into the sylvian fissure and sometimes intraparenchymally, and their bleed location is theoretically the most distant from the contralateral cistern or fissure.
When stratifying the risk for symptomatic vasospasm (or clinical deterioration due to delayed cerebral ischemia) using the BNI scale, the higher the grade, the more likely the risk for vasospasm. Comparing patients with a BNI scale grade of 5 to patients with a grade of 1 produced an odds ratio greater than 11. Aneurysms of the pericallosal artery may have a significantly higher risk for symptomatic vasospasm than other aneurysms of similar BNI scale score, demonstrated by ruptured pericallosal artery aneurysms harboring the lowest mean maximum clot thickness and highest rates of vasospasm. We also found that a significantly higher mean clot thickness was found in patients with stroke (cerebral infarction) from vasospasm than those without (9.71 vs 6.15 mm, p = 0.004). Our results also show that the mean size of aneurysms did not differ by BNI scale grade; that is, larger aneurysms were no more likely to have a higher maximum SAH clot burden using the BNI scale. Similarly, while there was a slight linear relationship between aneurysm size and clot thickness, it was not significant (p = 0.1085). Patients with lower VA aneurysms had the worst overall mean 1-year mRS scores; the difference between outcomes in patients with these aneurysms and all others was significant (p = 0.0249). The reason for this difference may be the increased morbidity associated with bleeds in the vicinity of the lower cranial nerves, associated with an increased risk of ventilator dependency and swallowing dysfunction, and later in the need for tracheostomy and percutaneous feeding tube placement. In the overall BRAT cohort, 6 patients with PICA aneurysms underwent clip placement more often than coil embolization; those with VA aneurysms not at PICA underwent coil embolization more often. Of the 16 patients in this study, 9 underwent clip placement (mostly PICA aneurysms) and 7 underwent coil embolization (mostly non-PICA VA aneurysms).
This report inherently exhibits some of the limitations of a retrospective study, as not all of the data collected was part of a prospective randomized controlled trial, nor were some of the outcome measures discussed here decided upon prior to study initiation. Furthermore, it should be noted that certain patients were excluded in this study, including 1 patient who died before treatment, 2 patients without admission CT scans available for review, 2 patients with ICA aneurysms with a cavernous location, and 29 patients with nonaneurysmal SAH. Additionally, outcomes documented in this study cannot be generalized to the BRAT study: these are patients in whom additional data were analyzed retrospectively and the study does not involve the entire BRAT population. This vasospasm study includes those patients in whom vasospasm data were collected and who were selected at random, as has been previously reported. 9 
Conclusions
In this study, we found that there is some variability in the thickness of SAH relative to the site of the ruptured aneurysm, but the differences in clot thickness and BNI scale grade between different aneurysm locations overall were not statistically significant. Although it was evident in a small sample of 9 patients, aneurysms of the pericallosal artery, which rupture into the interhemispheric fissure, have a statistically significantly greater risk of symptomatic vasospasm despite having the lowest mean clot thickness. Additionally, there was a higher mean clot thickness in the 14 patients who were found to have infarct attributable to vasospasm (p = 0.004). The patients in this study were also found to have worse mean 1-year mRS outcome when they harbored aneurysms of the VA location (including the PICA); furthermore, patients had a lower proportion of good outcomes (mRS score 0-2) when aneurysms were located in the posterior circulation or pericallosal arteries. 
